Bank of New York Mellon Corp - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 44 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$308,868
-61.0%
300,000
-62.5%
0.00%
Q1 2024$791,976
-6.2%
800,0000.0%0.00%
Q4 2023$843,904
+7.9%
800,0000.0%0.00%
Q3 2023$782,344
+65.1%
800,000
+60.0%
0.00%
Q2 2023$473,865
+3.9%
500,0000.0%0.00%
Q1 2023$456,040
+63.8%
500,000
+66.7%
0.00%
Q4 2022$278,429
-44.2%
300,000
-40.0%
0.00%
Q3 2022$499,000
+9.4%
500,0000.0%0.00%
Q2 2022$456,000500,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 127,800,000$128,518,0002.56%
WOLVERINE ASSET MANAGEMENT LLC 107,030,000$106,622,0001.15%
MACKAY SHIELDS LLC 24,472,000$24,283,0000.61%
SSI INVESTMENT MANAGEMENT LLC 6,945,000$6,865,0000.46%
ADVENT CAPITAL MANAGEMENT /DE/ 20,000,000$19,863,0000.36%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,500,000$15,433,0000.35%
Magnetar Financial LLC 16,700,000$16,606,0000.23%
CAMDEN ASSET MANAGEMENT L P /CA 4,300,000$4,249,0000.14%
CAPSTONE INVESTMENT ADVISORS, LLC 18,700,000$18,571,0000.11%
RWC Asset Management LLP 2,500,000$2,497,0000.08%
View complete list of IONIS PHARMACEUTICALS INC shareholders